Back to search

Poland· PL-100522141

Bengay Maść Przeciwbólowa

A sonstige topische präparate bei gelenk- und muskelschmerzen product containing methylis salicylas + mentholum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 6 of our 19 countries.

ATC M02AX10

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBengay Maść PrzeciwbólowaATCM02AX10REGISTER NO.PL-100522141PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Sonstige topische präparate bei gelenk- und muskelschmerzen is registered in 6 of 19 countries.

Countries holding a registration under ATC M02AX10 (sonstige topische präparate bei gelenk- und muskelschmerzen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Sonstige topische präparate bei gelenk- und muskelschmerzen · ATC M02AX10

6 / 19 countries

  • Belgiumprice
  • Canada
  • Ireland
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Methylis salicylas + Mentholum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
M02AX10
ATC class
Sonstige topische Präparate bei Gelenk- und Muskelschmerzen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991581671

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sonstige topische präparate bei gelenk- und muskelschmerzen in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sonstige topische präparate bei gelenk- und muskelschmerzen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c0da5fcd-6a83-4083-a06c-66d3603969de
GET /v1/drugs/c0da5fcd-6a83-4083-a06c-66d3603969de?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Maść",
  "source": "urpl",
  "strength": "(150 mg + 100 mg)/g",
  "packaging": "05909991581671 ¦ OTC ¦ 163078\n1 tuba 50 g",
  "substance": null,
  "common_name": "Methylis salicylas + Mentholum",
  "pl_product_id": "100522141",
  "pozwolenie_nr": "253/25",
  "auth_procedure": "IR",
  "authorisation_validity": "2030-07-29"
}

See everything about sonstige topische präparate bei gelenk- und muskelschmerzen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.